In the global Ursodeoxycholic Acid Market, cholestatic liver illnesses are at the forefront of driving demand. Gallstones and cystic fibrosis are two of the most common conditions that are driving the market. According to the Cystic Fibrosis Foundation, around 30,000 persons in the United States have cystic fibrosis.
When compared to men, women are more likely to have gallstones. This is primarily due to elevated estrogen levels during pregnancy, hormone replacement therapy, and birth control pill use. Gallstones are also more common in elderly persons, as well as those who have a family history of gallstones. While surgery is the most common treatment, ursodeoxycholic acid can dissolve tiny stones that are primarily made of cholesterol. This has a beneficial effect on the stock market.
Read more @ https://creativeedge16.blogspot.com/2022/02/global-ursodeoxycholic-acid-market-was.html
